JonesTrading Strengthens Global Derivatives Biz

Nov 19 2008 | 8:49am ET

Agency brokerage JonesTrading Institutional Services has recruited industry veteran Tom Steen to head its global derivatives business. Steen will also head up an expansion of JonesTrading's Canadian Equity platform.

The firm’s newest managing director will report to Will Geyer, JonesTrading president and chief executive officer, and to Steve Tullar, national sales manager.

Most recently, Steen was head of risk management and business development at DDX Capital Partners. 

“During these difficult times in the financial markets, traders are increasingly relying on relationship-based trading,” said Packy Jones, chairman of JonesTrading. “We have been committed, over the course of the last two years, to offering our institutional and hedge fund clients a greater suite of securities instruments. This latest expansion into global derivatives and an increased focus on Canadian equities is in anticipation of client demand for our model in these securities.”

According to the firm, the JonesTrading global derivatives platform will bring hedging, risk control and return enhancement capabilities to the firm's clients through the use of listed derivatives. It is estimated that there are 3,000-listed options on single stocks, ETFs and indices, and they will now be available for trading through the platform.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

The healthcare sector went on a tear beginning in 2011, thanks in large part to the passage of the Affordable Care Act and its impending implementat